跳至主要内容
临床试验/NL-OMON27144
NL-OMON27144招募中不适用

ndercarboxylated osteocalcin, the hypothalamic-pituitary-gonadal axis and glucose metabolism in male patients with osteoporosis.

Academic Medical Center (AMC) Amsterdam0 个研究点目标入组 8 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
8

研究概览

简要总结

A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male sex 50-80 years;
  • 2. Recently diagnosed primary osteoporosis (T-score between -2.5 and -3.5);

排除标准

  • 1. Contraindication to parathyroid hormone therapy: hypersensitivity to the active substrate or to any of the excipients, pre-existing hypercalcaemia, hepatic- or renal insufficiency, metabolic bone diseases other than primary osteoporosis or glucocorticoid-induced osteoporosis, unexplained elevations of alkaline phosphatase, prior external beam or implant radiation therapy to the skeleton, patients with skeletal malignancies or bone metastases;
  • 2. Any medication or disease influencing bone turnover;

研究者

发起方
Academic Medical Center (AMC) Amsterdam

相似试验

Bone, testosterone and glucose metabolism. | 临床试验